ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Mebucaine N, Lutschtabletten (neue Formel):Spirig HealthCare AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
R02AA06 - CetylpyridiniumATC-DDD Version 2016. Source: WHO
R - Respiratory System

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.

R02 - Throat Preparations
 
R02A - Throat Preparations

Throat preparations and mouth preparations are classified in the groups R02 and A01 according to assumed main therapeutic use. Preparations used in common minor infections of mouth and throat are classified in R02, while preparations used in gingivitis, stomatitis etc. are classified in A01 - Stomatological preparations.
Preparations for the treatment of symptoms both in mouth and throat are classified in R02 - Throat preparations.

The DDDs are based on the treatment of common minor infections of mouth and throat. For combination products, DDDs are given as fixed doses of 6 UD (6 tablets).

R02AA - Antiseptics

See also A01AB - Antiinfectives and antiseptics for local oral treatment.
At each 5th level combinations with anesthetics are allowed.
The combination dichlorobenzyl alcohol and amyl-m-cresol is classified in R02AA03.
Combinations of cetylpyridinium and lysozyme are classified in R02AA06.

R02AA06 - Cetylpyridinium
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home